疟疾
青蒿素
抗药性
药品
恶性疟原虫
药物发现
东南亚
传染病(医学专业)
疾病
医学
重症监护医学
生物
药理学
免疫学
生物信息学
微生物学
历史
古代史
病理
作者
Thomas Martin Schäfer,Laís Pessanha de Carvalho,Juliana Inoue,Andrea Kreidenweiss,Jana Held
标识
DOI:10.1080/17460441.2023.2284820
摘要
While employing strategies that utilize already approved drugs may offer a prompt and cost-effective approach to counter antimalarial drug resistance, it is crucial to recognize that only continuous efforts into the development of novel antimalarial drugs can ensure the successful treatment of malaria in the future. Incorporating resistance propensity assessment during this developmental process will increase the likelihood of effective and enduring malaria treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI